VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,788,069 | +65.5% | 74,305 | +62.2% | 0.00% | 0.0% |
| Q2 2023 | $2,288,350 | +17648.8% | 45,822 | +13220.3% | 0.00% | – |
| Q1 2023 | $12,893 | -99.8% | 344 | -99.7% | 0.00% | -100.0% |
| Q4 2022 | $5,884,424 | +294121.2% | 122,720 | +163526.7% | 0.00% | – |
| Q3 2022 | $2,000 | -99.6% | 75 | -99.7% | 0.00% | – |
| Q2 2022 | $513,000 | -64.8% | 23,573 | -61.0% | 0.00% | – |
| Q1 2022 | $1,458,000 | +35.5% | 60,387 | +33.5% | 0.00% | – |
| Q4 2021 | $1,076,000 | -65.2% | 45,235 | -62.9% | 0.00% | -100.0% |
| Q3 2021 | $3,091,000 | +27.3% | 121,787 | +12.9% | 0.00% | 0.0% |
| Q2 2021 | $2,429,000 | +6.5% | 107,903 | -6.5% | 0.00% | 0.0% |
| Q1 2021 | $2,280,000 | +25.9% | 115,450 | +69.4% | 0.00% | 0.0% |
| Q4 2020 | $1,811,000 | +4930.6% | 68,166 | +9367.5% | 0.00% | – |
| Q3 2020 | $36,000 | – | 720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |